The Value of In Vitro Drug Activity and Pharmacokinetics in Predicting the Effectiveness of Anti mycobacterial Therapy: A Critical Review

WJ Burman - The American journal of the medical sciences, 1997 - Elsevier
… the MIC for most of the time the patient is taking the drug. This review will evaluate how well
this paradigm predicts the effectiveness of treatment with antimycobacterial agents. Common …

In vitro pharmacokinetic/pharmacodynamic models in anti-infective drug development: focus on TB

PK Vaddady, RE Lee, B Meibohm - Future medicinal chemistry, 2010 - Future Science
… suitable animal models to predict efficacy, a poor understanding of … Since antimicrobial
efficacy in an in vitro model relates to the rate … A critical review of PK/PD in in vitro models. Int. J. …

Pharmacokinetic-pharmacodynamic modeling of antibacterial drugs

EI Nielsen, LE Friberg - Pharmacological reviews, 2013 - ASPET
… valuable for early predictions of a drug effect, where … review provides an overview of available
pharmacokinetic-pharmacodynamic models of antibacterial drugs that are based on in vitro

Developments in PK/PD: optimising efficacy and prevention of resistance. A critical review of PK/PD in in vitro models

A MacGowan, K Bowker - International journal of antimicrobial agents, 2002 - Elsevier
… In vitro pharmacokinetic models are excellent tools with which to study an antibacterial's
parameters which predict fluoroquinolone antibacterial effect and emergence of resistance …

Pharmacokinetic and pharmacodynamic issues in the treatment of mycobacterial infections

E Nuermberger, J Grosset - European Journal of Clinical Microbiology and …, 2004 - Springer
… of antibacterial agents, treatment typically requires the use of … convincing in vitro models to
predict the sterilizing activity of … to ascertain the predictive value of these pharmacokinetic and …

[HTML][HTML] The importance of pharmacokinetics and pharmacodynamics in antimicrobial drug development and their influence on the success of agents developed to …

ME Palmer, LJ Andrews, TC Abbey… - Frontiers in …, 2022 - frontiersin.org
Frontiers | The importance of pharmacokinetics and pharmacodynamics in antimicrobial drug
development and their influence on the success of agents developed to combat resistant …

Comprehensive physicochemical, pharmacokinetic and activity profiling of anti-TB agents

SB Lakshminarayana, TB Huat, PC Ho… - … of Antimicrobial …, 2015 - academic.oup.com
… , in vitro and in vivo pharmacokinetic and pharmacodynamic … is not a predictor of activity
inside the mycobacterium, at least … compounds, mouse in vivo PK and efficacy data were either …

Pharmacokinetic-pharmacodynamic and dose-response relationships of antituberculosis drugs: recommendations and standards for industry and academia

T Gumbo, I Angulo-Barturen… - The Journal of …, 2015 - academic.oup.com
… of antimicrobial effect include microbial kill, acquired drug … can be calculated ex vivo and then
translated to the clinic. … C max /MIC as most predictive of speed of sterilizing effect, whereas …

An oracle: antituberculosis pharmacokinetics-pharmacodynamics, clinical correlation, and clinical trial simulations to predict the future

J Pasipanodya, T Gumbo - Antimicrobial agents and …, 2011 - Am Soc Microbiol
pharmacokinetic data or had a dose-scheduling design. Without exception, the antimicrobial
PK/PD parameters linked to optimal effect … Thus, exposure-effect relationships derived in the …

Using pharmacokinetics and pharmacodynamics to optimise dosing of antifungal agents in critically ill patients: a systematic review

M Sinnollareddy, SL Peake, MS Roberts… - … journal of antimicrobial …, 2012 - Elsevier
review provides a critical analysis of the pharmacokinetics of … is the predictive PD parameter
related to maximum efficacy. … In vitro and in vivo PD studies have demonstrated that C max …